Inhibition of hepatitis C virus nonstructural protein, helicase activity, and viral replication by a recombinant human antibody clone. Morgenstern, K. A. et al.
Proof of concept for this class of inhibitors has been demonstrated by Boehringer Ingelheim and Vertex Pharmaceuticals using BILN-2061In contrast, HCV polymerase high-throughput assays for elongation have generally been fruitful and yielded a diverse group of active-site and non-active-site inhibitors with different scaffolds. Richman, D. D. The implications of drug resistance for strategies of combination antiviral chemotherapy. The availability of multiple starting points for HCV polymerase inhibitors means that there is a wealth of companies with preclinical inhibitors, some of which have shown good potency and good bioavailability. This transcript is cleaved at several sites in order to separate the individual rRNA sequences, generating three fragments which are then further trimmed until only the rRNA sequences remain (To date, at least 20 RNA helicases have been implicated as eukaryotic RB factors (We use cookies to help provide and enhance our service and tailor content and ads. Tackett, A. J., Chen, Y., Cameron, C. E. & Raney, K. D. Multiple full-length NS3 molecules are required for optimal unwinding of oligonucleotide DNA Frick, D. N., Rypma, R. S., Lam, A. M. & Gu, B.
Gallinari, P. et al. Hong, Z. et al.
Virology 328:208–218 [Google Scholar]
Kleymann, G. et al. Structure of the hepatitis C virus RNA helicase domain. Porter, D. J. et al.
Gallinari, P. et al.
Each family has distinct structural and functional properties.
Fairman, M. E. et al. Yedavalli, V. S., Neuveut, C., Chi, Y. H., Kleiman, L. & Jeang, K. T. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Lohman, T. M. & Bjornson, K. P. Mechanisms of helicase-catalyzed DNA unwinding.
10 Apparently a sufficiently diverse repertoire of cellular RNA helicase proteins is available to support most viral replication strategies.
Wilson, V. G., West, M., Woytek, K. & Rangasamy, D. Papillomavirus E1 proteins: form, function, and features.
NM283 (Idenix) has provided proof of concept for active-site polymerase inhibitors with Because there are multiple mechanisms of action that could inhibit HCV helicase, many have been surprised at the meagre array of hits from helicase screens or focused chemical librariesIt is not hard to imagine that the development of HCV helicase inhibitors for clinical use has been slow because the enzyme is a moving target and undergoes significant transient conformational changes that require the coupling of NTP hydrolysis to unwindingSuperimposition of independent hepatitis C virus helicase structures. -L. Minireview: virus-encoded RNA helicases. Salonen, A., Ahola, T. & Kaariainen, L. Viral RNA replication in association with cellular membranes. Protein displacement by DExH/D “RNA helicases” without duplex unwinding. Sign up for the Get the most important science stories of the day, free in your inbox. ATP-binding domain of NTPase/helicase as a target for hepatitis C antiviral therapy. Synthesis and evaluation of ATP-binding site directed potential inhibitors of nucleoside triphosphatases/helicases and polymerases of hepatitis C and other selected Flaviviridae viruses. Singleton, M. R. & Wigley, D. B. Modularity and specialization in superfamily 1 and 2 helicases. & Wigley, D. B.
Inhibition of herpes simplex virus type 1 helicase–primase by (dichloroanilino)purines and-pyrimidines. The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently.